0001613103-23-000152.txt : 20231206 0001613103-23-000152.hdr.sgml : 20231206 20231206160525 ACCESSION NUMBER: 0001613103-23-000152 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20231206 ITEM INFORMATION: Other Events FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0426 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 231469642 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20231206.htm 8-K mdt-20231206
0001613103Medtronic plcD02 XH02false00016131032023-12-062023-12-060001613103us-gaap:CommonStockMember2023-12-062023-12-060001613103mdt:SeniorNotes2019Due2025Member2023-12-062023-12-060001613103mdt:SeniorNotes2020Due2025Member2023-12-062023-12-060001613103mdt:SeniorNotes2022Due2025Member2023-12-062023-12-060001613103mdt:SeniorNotes2019Due2027Member2023-12-062023-12-060001613103mdt:A2020SeniorNotesDue2028Member2023-12-062023-12-060001613103mdt:SeniorNotes2022Due2028Member2023-12-062023-12-060001613103mdt:SeniorNotes2019Due20311.625PercentMember2023-12-062023-12-060001613103mdt:SeniorNotes2022Due20313125PercentMember2023-12-062023-12-060001613103mdt:SeniorNotes2022Due2031Member2023-12-062023-12-060001613103mdt:A2020SeniorNotesDue2032Member2023-12-062023-12-060001613103mdt:SeniorNotes2022Due2034Member2023-12-062023-12-060001613103mdt:SeniorNotes2019Due20392.250PercentMember2023-12-062023-12-060001613103mdt:SeniorNotes2019Due20391.50PercentMember2023-12-062023-12-060001613103mdt:SeniorNotes2020Due2040Member2023-12-062023-12-060001613103mdt:SeniorNotes2019Due2049Member2023-12-062023-12-060001613103mdt:SeniorNotes2020Due2050Member2023-12-062023-12-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________ 
FORM 8-K
 _____________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 6, 2023
 _____________________________ 
Medtronic plc
(Exact Name of Registrant as Specified in its Charter)
  _____________________________ 
 
Ireland 1-36820 98-1183488
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
(Address of principal executive offices)
+353 1 438-1700
(Registrant’s telephone number, including area code)
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))












Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered
Ordinary Shares, $0.0001 par value per shareMDTNew York Stock Exchange
0.250% Senior Notes due 2025MDT/25New York Stock Exchange
0.000% Senior Notes due 2025MDT/25ANew York Stock Exchange
2.625% Senior Notes due 2025MDT/25BNew York Stock Exchange
1.125% Senior Notes due 2027MDT/27New York Stock Exchange
0.375% Senior Notes due 2028MDT/28New York Stock Exchange
3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange
1.625% Senior Notes due 2031MDT/31New York Stock Exchange
1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange
3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange
0.750% Senior Notes due 2032MDT/32New York Stock Exchange
3.375% Senior Notes due 2034MDT/34New York Stock Exchange
2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange
1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange
1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange
1.750% Senior Notes due 2049MDT/49New York Stock Exchange
1.625% Senior Notes due 2050MDT/50New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 8.01Other Events.
On May 25, 2023, Medtronic plc (Medtronic) announced that it had entered into a set of definitive agreements (Agreements) to acquire EOFlow Co. Ltd. (EOFlow) (KOSDAQ: 294090) pursuant to a share purchase agreement, a share subscription agreement, and a public tender offer, subject to the satisfaction of the minimum tender condition and certain customary closing conditions, including receipt of required regulatory clearances. On December 6, 2023, based upon multiple breaches under the Agreements, Medtronic delivered notice to EOFlow that it had exercised its right to terminate the Agreements. Medtronic does not believe any termination fee is payable under the Agreements. The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   Medtronic plc
Date: December 6, 2023  By /s/ Karen L. Parkhill
   Karen L. Parkhill
   Executive Vice President and Chief Financial Officer





 EX-101.SCH 2 mdt-20231206.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 mdt-20231206_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 mdt-20231206_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key 0.000% Senior Notes due 2025 Senior Notes 2020 Due 2025 [Member] Senior Notes 2020 Due 2025 Entity Address, Address Line One Entity Address, Address Line One 2.625% Senior Notes due 2025 Senior Notes 2022 Due 2025 [Member] Senior Notes 2022 Due 2025 Trading Symbol Trading Symbol Entity File Number Entity File Number 1.375% Senior Notes due 2040 Senior Notes 2020 Due 2040 [Member] Senior Notes 2020 Due 2040 1.500% Senior Notes due 2039 Senior Notes 2019 Due 2039, 1.50 Percent [Member] Senior Notes 2019 Due 2039, 1.50 Percent [Member] Soliciting Material Soliciting Material Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Class of Stock [Domain] Class of Stock [Domain] 1.750% Senior Notes due 2049 Senior Notes 2019 Due 2049 [Member] Senior Notes 2019 Due 2049 [Member] City Area Code City Area Code Entities [Table] Entities [Table] Title of 12(b) Security Title of 12(b) Security 1.625% Senior Notes due 2050 Senior Notes 2020 Due 2050 [Member] Senior Notes 2020 Due 2050 Amendment Flag Amendment Flag Entity Information [Line Items] Entity Information [Line Items] 3.000% Senior Notes due 2028 Senior Notes 2022 Due 2028 [Member] Senior Notes 2022 Due 2028 Entity Registrant Name Entity Registrant Name Security Exchange Name Security Exchange Name 0.375% Senior Notes due 2028 2020 Senior Notes Due 2028 [Member] 2020 Senior Notes Due 2028 Document Period End Date Document Period End Date Entity Tax Identification Number Entity Tax Identification Number Ordinary Shares, $0.0001 par value per share Common Stock [Member] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer 3.125% Senior Notes due 2031 Senior Notes 2022 Due 2031 [Member] Senior Notes 2022 Due 2031 0.250% Senior Notes due 2025 Senior Notes 2019 Due 2025 [Member] Senior Notes 2019 Due 2025 [Member] Entity Address, City or Town Entity Address, City or Town Class of Stock [Axis] Class of Stock [Axis] 0.750% Senior Notes due 2032 2020 Senior Notes Due 2032 [Member] 2020 Senior Notes Due 2032 Local Phone Number Local Phone Number 1.625% Senior Notes due 2031 Senior Notes 2019 Due 2031, 1.625 Percent [Member] Senior Notes 2019 Due 2031, 1.625 Percent [Member] Entity Address, Country Entity Address, Country Written Communications Written Communications Cover page. Cover [Abstract] 1.000% Senior Notes due 2031 Senior Notes 2022 Due 2031, 3.125 Percent [Member] Senior Notes 2022 Due 2031, 3.125 Percent [Member] 2.250% Senior Notes due 2039 Senior Notes 2019 Due 2039, 2.250 Percent [Member] Senior Notes 2019 Due 2039, 2.250 Percent [Member] Document Type Document Type 3.375% Senior Notes due 2034 Senior Notes 2022 Due 2034 [Member] Senior Notes 2022 Due 2034 Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Country Region Country Region 1.125% Senior Notes due 2027 Senior Notes 2019 Due 2027 [Member] Senior Notes 2019 Due 2027 [Member] EX-101.PRE 5 mdt-20231206_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document And Entity Information
Dec. 06, 2023
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Dec. 06, 2023
Entity Incorporation, State or Country Code L2
Entity File Number 1-36820
Entity Tax Identification Number 98-1183488
Entity Address, Address Line One 20 On Hatch, Lower Hatch Street
Entity Address, City or Town Dublin 2
Entity Address, Country IE
Country Region 353
City Area Code 1
Local Phone Number 438-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001613103
Entity Registrant Name Medtronic plc
Entity Address, Postal Zip Code D02 XH02
Amendment Flag false
Ordinary Shares, $0.0001 par value per share  
Entity Information [Line Items]  
Title of 12(b) Security Ordinary Shares, $0.0001 par value per share
Trading Symbol MDT
Security Exchange Name NYSE
0.250% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.250% Senior Notes due 2025
Trading Symbol MDT/25
Security Exchange Name NYSE
0.000% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2025
Trading Symbol MDT/25A
Security Exchange Name NYSE
1.125% Senior Notes due 2027  
Entity Information [Line Items]  
Title of 12(b) Security 1.125% Senior Notes due 2027
Trading Symbol MDT/27
Security Exchange Name NYSE
0.375% Senior Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 0.375% Senior Notes due 2028
Trading Symbol MDT/28
Security Exchange Name NYSE
3.000% Senior Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 3.000% Senior Notes due 2028
Trading Symbol MDT/28A
Security Exchange Name NYSE
1.625% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2031
Trading Symbol MDT/31
Security Exchange Name NYSE
1.000% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.000% Senior Notes due 2031
Trading Symbol MDT/31A
Security Exchange Name NYSE
0.750% Senior Notes due 2032  
Entity Information [Line Items]  
Title of 12(b) Security 0.750% Senior Notes due 2032
Trading Symbol MDT/32
Security Exchange Name NYSE
2.250% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 2.250% Senior Notes due 2039
Trading Symbol MDT/39A
Security Exchange Name NYSE
1.500% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 1.500% Senior Notes due 2039
Trading Symbol MDT/39B
Security Exchange Name NYSE
1.375% Senior Notes due 2040  
Entity Information [Line Items]  
Title of 12(b) Security 1.375% Senior Notes due 2040
Trading Symbol MDT/40A
Security Exchange Name NYSE
1.750% Senior Notes due 2049  
Entity Information [Line Items]  
Title of 12(b) Security 1.750% Senior Notes due 2049
Trading Symbol MDT/49
Security Exchange Name NYSE
1.625% Senior Notes due 2050  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2050
Trading Symbol MDT/50
Security Exchange Name NYSE
3.375% Senior Notes due 2034  
Entity Information [Line Items]  
Title of 12(b) Security 3.375% Senior Notes due 2034
Trading Symbol MDT/34
Security Exchange Name NYSE
3.125% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 3.125% Senior Notes due 2031
Trading Symbol MDT/31B
Security Exchange Name NYSE
2.625% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 2.625% Senior Notes due 2025
Trading Symbol MDT/25B
Security Exchange Name NYSE
XML 7 mdt-20231206_htm.xml IDEA: XBRL DOCUMENT 0001613103 2023-12-06 2023-12-06 0001613103 us-gaap:CommonStockMember 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2019Due2025Member 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2020Due2025Member 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2022Due2025Member 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2019Due2027Member 2023-12-06 2023-12-06 0001613103 mdt:A2020SeniorNotesDue2028Member 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2022Due2028Member 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2019Due20311.625PercentMember 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2022Due20313125PercentMember 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2022Due2031Member 2023-12-06 2023-12-06 0001613103 mdt:A2020SeniorNotesDue2032Member 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2022Due2034Member 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2019Due20392.250PercentMember 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2019Due20391.50PercentMember 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2020Due2040Member 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2019Due2049Member 2023-12-06 2023-12-06 0001613103 mdt:SeniorNotes2020Due2050Member 2023-12-06 2023-12-06 0001613103 Medtronic plc D02 XH02 false 8-K 2023-12-06 L2 1-36820 98-1183488 20 On Hatch, Lower Hatch Street Dublin 2 IE 353 1 438-1700 false false false false Ordinary Shares, $0.0001 par value per share MDT NYSE 0.250% Senior Notes due 2025 MDT/25 NYSE 0.000% Senior Notes due 2025 MDT/25A NYSE 2.625% Senior Notes due 2025 MDT/25B NYSE 1.125% Senior Notes due 2027 MDT/27 NYSE 0.375% Senior Notes due 2028 MDT/28 NYSE 3.000% Senior Notes due 2028 MDT/28A NYSE 1.625% Senior Notes due 2031 MDT/31 NYSE 1.000% Senior Notes due 2031 MDT/31A NYSE 3.125% Senior Notes due 2031 MDT/31B NYSE 0.750% Senior Notes due 2032 MDT/32 NYSE 3.375% Senior Notes due 2034 MDT/34 NYSE 2.250% Senior Notes due 2039 MDT/39A NYSE 1.500% Senior Notes due 2039 MDT/39B NYSE 1.375% Senior Notes due 2040 MDT/40A NYSE 1.750% Senior Notes due 2049 MDT/49 NYSE 1.625% Senior Notes due 2050 MDT/50 NYSE false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 18 23 1 false 17 0 false 0 false false R1.htm 0000001 - Document - Document And Entity Information Sheet http://www.medtronic.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports mdt-20231206.htm mdt-20231206.xsd mdt-20231206_def.xml mdt-20231206_lab.xml mdt-20231206_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "mdt-20231206.htm": { "nsprefix": "mdt", "nsuri": "http://www.medtronic.com/20231206", "dts": { "inline": { "local": [ "mdt-20231206.htm" ] }, "schema": { "local": [ "mdt-20231206.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] }, "definitionLink": { "local": [ "mdt-20231206_def.xml" ] }, "labelLink": { "local": [ "mdt-20231206_lab.xml" ] }, "presentationLink": { "local": [ "mdt-20231206_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 16, "hidden": { "total": 4, "http://xbrl.sec.gov/dei/2022": 4 }, "contextCount": 18, "entityCount": 1, "segmentCount": 17, "elementCount": 45, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 71 }, "report": { "R1": { "role": "http://www.medtronic.com/role/DocumentAndEntityInformation", "longName": "0000001 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mdt-20231206.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mdt-20231206.htm", "first": true, "unique": true } } }, "tag": { "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CountryRegion", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Country Region", "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CommonStockMember", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Shares, $0.0001 par value per share", "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "WrittenCommunications", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover page.", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "mdt_SeniorNotes2019Due2049Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2019Due2049Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.750% Senior Notes due 2049", "label": "Senior Notes 2019 Due 2049 [Member]", "documentation": "Senior Notes 2019 Due 2049 [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SolicitingMaterial", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "mdt_SeniorNotes2019Due20391.50PercentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2019Due20391.50PercentMember", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.500% Senior Notes due 2039", "label": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]", "documentation": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ClassOfStockDomain", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "mdt_SeniorNotes2019Due2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2019Due2027Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.125% Senior Notes due 2027", "label": "Senior Notes 2019 Due 2027 [Member]", "documentation": "Senior Notes 2019 Due 2027 [Member]" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "mdt_SeniorNotes2022Due2034Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2022Due2034Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "3.375% Senior Notes due 2034", "label": "Senior Notes 2022 Due 2034 [Member]", "documentation": "Senior Notes 2022 Due 2034" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "mdt_SeniorNotes2020Due2040Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2020Due2040Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.375% Senior Notes due 2040", "label": "Senior Notes 2020 Due 2040 [Member]", "documentation": "Senior Notes 2020 Due 2040" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntitiesTable", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "mdt_SeniorNotes2022Due2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2022Due2025Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "2.625% Senior Notes due 2025", "label": "Senior Notes 2022 Due 2025 [Member]", "documentation": "Senior Notes 2022 Due 2025" } } }, "auth_ref": [] }, "mdt_SeniorNotes2020Due2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2020Due2025Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "0.000% Senior Notes due 2025", "label": "Senior Notes 2020 Due 2025 [Member]", "documentation": "Senior Notes 2020 Due 2025" } } }, "auth_ref": [] }, "mdt_SeniorNotes2022Due20313125PercentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2022Due20313125PercentMember", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.000% Senior Notes due 2031", "label": "Senior Notes 2022 Due 2031, 3.125 Percent [Member]", "documentation": "Senior Notes 2022 Due 2031, 3.125 Percent [Member]" } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityInformationLineItems", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information [Line Items]", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "mdt_A2020SeniorNotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "A2020SeniorNotesDue2028Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "0.375% Senior Notes due 2028", "label": "2020 Senior Notes Due 2028 [Member]", "documentation": "2020 Senior Notes Due 2028" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "mdt_SeniorNotes2019Due2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2019Due2025Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "0.250% Senior Notes due 2025", "label": "Senior Notes 2019 Due 2025 [Member]", "documentation": "Senior Notes 2019 Due 2025 [Member]" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "mdt_SeniorNotes2022Due2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2022Due2028Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "3.000% Senior Notes due 2028", "label": "Senior Notes 2022 Due 2028 [Member]", "documentation": "Senior Notes 2022 Due 2028" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "mdt_SeniorNotes2019Due20311.625PercentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2019Due20311.625PercentMember", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.625% Senior Notes due 2031", "label": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]", "documentation": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]" } } }, "auth_ref": [] }, "mdt_SeniorNotes2020Due2050Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2020Due2050Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.625% Senior Notes due 2050", "label": "Senior Notes 2020 Due 2050 [Member]", "documentation": "Senior Notes 2020 Due 2050" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCountry", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Country", "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "mdt_A2020SeniorNotesDue2032Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "A2020SeniorNotesDue2032Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "0.750% Senior Notes due 2032", "label": "2020 Senior Notes Due 2032 [Member]", "documentation": "2020 Senior Notes Due 2032" } } }, "auth_ref": [] }, "mdt_SeniorNotes2022Due2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2022Due2031Member", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "3.125% Senior Notes due 2031", "label": "Senior Notes 2022 Due 2031 [Member]", "documentation": "Senior Notes 2022 Due 2031" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "mdt_SeniorNotes2019Due20392.250PercentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.medtronic.com/20231206", "localname": "SeniorNotes2019Due20392.250PercentMember", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "2.250% Senior Notes due 2039", "label": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]", "documentation": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001613103-23-000152-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001613103-23-000152-xbrl.zip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end